Bruno Ramos-Molina, PhD (@Brunorm84) header
Bruno Ramos-Molina, PhD (@Brunorm84) profile picture

Group Leader of the Obesity, Diabetes and Metabolism Lab at the Biomedical Research Institute of Murcia (IMIB) | PI & Research Professor (Tenured)

Murcia, Spain
Joined March 2009
🔎 We are looking for outstanding postdoctoral researchers interested in applying for the upcoming Juan de la Cierva (@AgEInves) and Sara Borrell (@SaludISCIII) fellowship calls to join the Obesity, Diabetes and Metabolism lab at @IMIB_RMurcia (Murcia,🇪🇸) under my supervision👇
1
8
18
1,666
Bruno Ramos-Molina, PhD retweeted
Correspondence: A Liver-Targeted 𝘊𝘐𝘋𝘌𝘉 siRNA in Adults with MASLD nej.md/4fcxkjE #TLM26 | @AASLDtweets
4
16
3
42
11,738
Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15 @MolMetab sciencedirect.com/science/ar…
7
24
1,491
Bruno Ramos-Molina, PhD retweeted
Presented at #TLM26: A single dose of an siRNA targeting liver expression of 𝘊𝘐𝘋𝘌𝘉 was associated with a reduction in liver fat of 58 to 80% at week 36 after treatment in persons with metabolic dysfunction–associated steatotic liver disease. Full trial results: nej.md/4fcxkjE @AASLDtweets
9
36
11
146
37,145
Bruno Ramos-Molina, PhD retweeted
Healthy remodeling of adipose tissue helps maintain metabolic balance and protect surrounding organs. But when this process is disrupted, it can lead to harmful cellular changes that contribute to metabolic disease and that damage nearby tissues. Although weight loss can reverse many aspects of fat-tissue dysfunction, some changes may persist. According to a new #ScienceReview, understanding which changes are reversible and which leave lasting effects is key to helping researchers develop treatments that don’t just reduce fat mass, but also restore healthy fat-tissue function and improve metabolic resilience. Learn more: scim.ag/4k0ob14
5
109
5
389
30,996
Gut #microbiome profiles associated with simple liver steatosis in #MASLD @Gut_BMJ gut.bmj.com/content/early/20…
5
12
860
Biological sex-dependent hormonal signaling and metabolomic profiles in #obesity alter tumor microenvironment and #immunotherapy outcomes @jclinicalinvest jci.org/articles/view/203453
4
20
966
Cycling GLP-1 receptor agonist treatment induces therapeutic resistance and increased adiposity #obesity @JCI_insight insight.jci.org/articles/vie…
4
24
5
107
13,000
Hyperactive mTORC1 underlies sex dimorphic progression of #MASLD in mice with hepatocyte prohibitin-1 deficiency @MolMetab sciencedirect.com/science/ar…
4
20
1,063
Bruno Ramos-Molina, PhD retweeted
The Scorletti Lab website at @HopkinsMedicine @HopkinsGIHep is now live: scorlettilab.com We are recruiting Postdoctoral Fellows to study cellular mechanisms underlying metabolic disease, aging, and cancer using iPSC-derived hepatocytes and organoids.
1
3
6
587
Neonatal overfeeding accelerates age-related sarcopenia and metabolic disorders through lifelong gut mucosa and microbiota programming in mice #aging #obesity @NatureComms nature.com/articles/s41467-0…
1
4
10
721
Bruno Ramos-Molina, PhD retweeted
🔬 Postdoctoral opportunity | Juan de la Cierva 2026 The @MolHepatolGC30 is looking for a talented postdoctoral researcher to join our team. 🧬 MASLD/MASH & HCC 🧬 RNA biology & tRNA/ARSs 🧬 Splicing & RNA metabolism 📩 Interested? Send your CV + short research statement
🤖 Made with AI
5
4
430
Microbiota-host genetic interactions modulate #MASLD risk in PNPLA3I148M carriers via ceramides and are reversible by targeted microbial interventions @Gut_BMJ gut.bmj.com/content/early/20…
3
9
782
Bruno Ramos-Molina, PhD retweeted
New! Online now: Fungus Rhizopus arrhizus promotes MASLD-associated hepatocellular carcinoma through generating kynurenic acid dlvr.​it/TVlT0b
2
21
52
3,633
Bruno Ramos-Molina, PhD retweeted
Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction dlvr.​it/TVl8W9
1
42
1
116
6,487